Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.73 is 41% below its 5-year average of 2.91, near the low end of its 5-year range (1.73–7.47).
As of the fiscal period ended Tuesday, June 30, 2026. 18.34% below its 12-month average of 2.11.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.73.
CURRENT RATIO
1.73
CURRENT RATIO AVG TTM
2.11
CURRENT RATIO AVG 3Y
2.48
CURRENT RATIO AVG 5Y
2.91
CURRENT RATIO AVG 10Y
5.43
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-18.34%
CURRENT VS 3Y AVG
-30.38%
CURRENT VS 5Y AVG
-40.72%
CURRENT VS 10Y AVG
-68.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-51.30%
vs the sector median at left
Ultragenyx Pharmaceutical Inc.
Market Cap
$1.44B
Current Ratio
1.73
TTM Avg
2.11
3Y Avg
2.48
5Y Avg
2.91
Market Cap
$1.45B
Current Ratio
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.41B
Current Ratio
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$1.46B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | $1.44B | 1.73 | 2.11 | 2.48 | 2.91 |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 5.61 | 9.29 | 11.65 | 16.84 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | 18.31 | 12.63 | 8.12 | 8.12 |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 1.20 | 1.17 | 1.13 | 1.04 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.46B | 2.55 | 2.09 | 2.53 | 2.95 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | 11.11 | 12.01 | 12.01 | 12.01 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 3.02 | 3.13 | 2.94 | 3.03 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | 5.07 | 3.94 | 5.82 | 5.62 |
| GH Research PLC (GHRS)vs › | $1.48B | 28.70 | 25.68 | 28.23 | 39.79 |
Current Ratio
1.73
Quick Ratio
1.56
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.73 |
| 2026-03-31 | 2.02 |
| 2025-12-31 | 2.48 |
| 2025-09-30 | 1.89 |
| 2025-06-30 | 2.45 |
| 2025-03-31 | 2.40 |
| 2024-12-31 | 2.37 |
| 2024-09-30 | 2.81 |
| 2024-06-30 | 3.54 |
| 2024-03-31 | 2.43 |
| 2023-12-31 | 2.61 |
| 2023-09-30 | 2.36 |
| 2023-06-30 | 2.87 |
| 2023-03-31 | 3.51 |
| 2022-12-31 | 3.38 |
| 2022-09-30 | 4.45 |
| 2022-06-30 | 3.08 |
| 2022-03-31 | 4.23 |
| 2021-12-31 | 4.72 |
| 2021-09-30 | 6.23 |
| 2021-06-30 | 7.47 |
| 2021-03-31 | 8.43 |
| 2020-12-31 | 6.83 |
| 2020-09-30 | 4.33 |
| 2020-06-30 | 4.12 |
| 2020-03-31 | 4.54 |
| 2019-12-31 | 8.24 |
| 2019-09-30 | 6.79 |
| 2019-06-30 | 9.33 |
| 2019-03-31 | 11.77 |
| 2018-12-31 | 6.99 |
| 2018-09-30 | 8.51 |
| 2018-06-30 | 8.28 |
| 2018-03-31 | 10.10 |
| 2017-12-31 | 3.44 |
| 2017-09-30 | 6.08 |
| 2017-06-30 | 6.70 |
| 2017-03-31 | 8.59 |
| 2016-12-31 | 8.27 |
| 2016-09-30 | 9.37 |
| 2016-06-30 | 12.85 |
| 2016-03-31 | 14.40 |
| 2015-12-31 | 16.13 |
| 2015-09-30 | 23.53 |
| 2015-06-30 | 14.61 |
| 2015-03-31 | 24.61 |
| 2014-12-31 | 14.98 |
| 2014-09-30 | 18.67 |
| 2014-06-30 | 17.69 |
| 2014-03-31 | 24.91 |
| 2013-12-31 | 9.33 |
| 2013-09-30 | 11.89 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 27.12 |
